Tri-Institutional Therapeutics Discovery Institute Has Selected Scilligence Informatics Platforms to Facilitate Drug Discovery R&D

Tri-Institutional Therapeutics Discovery Institute Has Selected Scilligence Informatics Platforms to Facilitate Drug Discovery R&D Boston, October 1, 2014 - Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) announces today that it has selected Scilligence ELN, RegMol and Inventory for facilitating collaborations and centralized data management in drug discovery R&D. “We...
Read More

Scilligence ELN Selected by WuXi AppTec for Knowledge Management and Collaboration

Scilligence ELN Selected by WuXi AppTec for Knowledge Management and Collaboration Boston, June 4, 2014 - Scilligence Corporation announces today that WuXi AppTec, a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company, has licensed Scilligence ELN for knowledge management and collaboration. Scilligence ELN, a cross-platform web-based ELN system, will enable ...
Read More
Go Back